Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 23;27(12):101588.
doi: 10.1016/j.gim.2025.101588. Online ahead of print.

Type and position of repeat interruptions as determinants of disease severity and expansion size in Friedreich ataxia

Collaborators, Affiliations

Type and position of repeat interruptions as determinants of disease severity and expansion size in Friedreich ataxia

Mehdi Benkirane et al. Genet Med. .

Abstract

Purpose: In Friedreich ataxia (FRDA) the size of the smaller GAA expansion is a major determinant of disease severity; interruption motifs were identified after the discovery of the pathogenic expansions; however, their impact is only recently investigated.

Methods: 164 patients with FRDA with biallelic expansions and 15 patients without FRDA were analyzed for interruption(s) number, position, and motif. Expansion size and age at onset of ataxia (AAO) were determined for patients with FRDA.

Results: Three groups of patients with FRDA were identified by the simultaneous analysis of the precise distance ("depth") between the interruptions (mostly nontriplet) and the 3' end of the expansion (P < .001), the smaller expansion size (P < .001), and AAO (P < .001). Classical FRDA corresponds to absence of interruption or interruption depth < 8 repeats, with AAO often <15 years (area under the curve [AUC] = 0.90; 95% CI, 0.84-0.96); LOFA to interruption depth of 8 to 18 repeats (AUC = 0.97; 95% CI, 0.94-1), with AAO 15 to 34 years (AUC = 1; 95% CI, 1-1); and vLOFA to interruption depth > 18 (AUC = 0.97; 95% CI, 0.92-1), with AAO > 34 years. Multiple (>5) triplet interruptions hamper further expansion.

Conclusion: This study provides the molecular basis for a novel classification of FRDA that should be recommended for correct diagnosis.

Keywords: Ataxia; FXN; Interruption depth; Nontriplet interruption; Triplet interruption.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Michel Koenig and Claire Ewenczyk are supported by Biogen for participation at an international congress. Cecilia Marelli received travel grants from Nutricia, Biogen, and Vitaflo for participation to national and international congress and is member of a BIOGEN Board. Cyril Goizet received consulting fees and honoraria for lectures from BIOGEN. Alexandra Durr serves as an advisor at Critical Path Ataxia Therapeutics Consortium, and her Institution (Paris Brain Institute) receives consulting fees on her behalf from Biogen, Huntix, UCB, as well as research grants from the NIH, ANR and holds partly a Patent B 06291873.5 on “Anaplerotic therapy of Huntington’s disease and other polyglutamine diseases.” Mathieu Anheim declares honoraria and travel grant from Biogen.

LinkOut - more resources